ArticleMolecular therapy. Oncology2026

Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/

Aleksei A Stepanenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.